Chronic Addiction, Compulsion, and the Empirical Evidence

AJOB Neuroscience

Volumn 3, Issue 2, 2012, Pages 58-59

  Dingel, Molly J ^a   Hammer, Rachel ^b   Ostergren, Jenny E ^b   McCormick, Jennifer B ^b   Koenig, Barbara A ^c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84860328969     PISSN: 21507740     EISSN: 21507759     Source Type: Journal    
DOI: 10.1080/21507740.2012.665411     Document Type: Article

References (10)

1. Claassen, L., Henneman, L., De Vet, R., Knol, D., Marteau, T. and Timmermans, D. 2010. Fatalistic responses to different types of genetic risk information: Exploring the role of self-malleability. Psychology and Health, 25(2): 183-196.
2. Dingel, M. J., Hicks, A. D., Robinson, M. E. and Koenig, B. A. 2011. Integrating genetic studies of nicotine addiction into public health practice: Stakeholder views on challenges, barriers and opportunities. Public Health Genomics, 15(1): 46-55.
3. Dingel, M. J., Partridge, B. J., Ostergren, J. E., Robinson, M. E., McCormick, J. B. and Koenig, B. A. 2011. How do patients define the utility of a genetic paradigm in substance-use treatment?. Alcoholism-Clinical and Experimental Research, 35(6): 196A
4. Dingel, M. J., Karkazis, K. and Koenig, B. A. 2011. Framing nicotine addiction as a "disease of the brain": Social and ethical consequences. Social Science Quarterly, 92(5): 1363-1388.
5. Edwards, G. 2003. Alcohol: The world's favorite drug, New York, NY: St. Martin's Griffin/Thomas Dunne Books.
6. Ho, M. K., Goldman, D.Heinz, A. 2010. Breaking barriers in the genomics and pharmacogenetics of drug addiction. Clinical Pharmacology & Therapeutics, 88(6): 779-791.
7. Kalivas, P. W. and Volkow, N. D. 2005. The neural basis of addiction: A pathology of motivation and choice. American Journal of Psychiatry, 162: 1403-1413.
8. Keeley, B., Wright, L. and Condit, C. M. 2009. Functions of health fatalism: Fatalistic talk as face saving, uncertainty management, stress relief and sense making. Sociology of Health & Illness, 31(5): 734-747.
9. Pickard, H. 2012. The purpose in chronic addiction. AJOB Neuroscience, 3(2): 40-49.
10. Sanderson, S. C. and Wardle, J. 2005. Will genetic testing for complex diseases increase motivation to quit smoking? Anticipated reactions in a survey of smokers. Health Education & Behavior, 32(5): 640-653.